Search Results - Kok, Klaartje B.

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Fecal Calprotectin in Gastrointestinal Disease

    Fecal Calprotectin in Gastrointestinal Disease by Murray, Jennifer, Kok, Klaartje B, Ayling, Ruth M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients

    Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients by Chanchlani, Neil, Lin, Simeng, Chee, Desmond, Hamilton, Benjamin, Nice, Rachel, Arkir, Zehra, Bewshea, Claire, Cipriano, Bessie, Derikx, Lauranne A A P, Dunlop, Allan, Greathead, Louise, Griffiths, Rachel L, Ibraheim, Hajir, Kelleher, Peter, Kok, Klaartje B, Lees, Charlie W, MacDonald, Jonathan, Sebastian, Shaji, Smith, Philip J, McDonald, Timothy J, Irving, Peter M, Powell, Nick, Kennedy, Nicholas A, Goodhand, James R, Ahmad, Tariq

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Provision of care for pregnant women with IBD in the UK: the current landscape

    Provision of care for pregnant women with IBD in the UK: the current landscape by Wolloff, Sarah, Moore, Emma, Glanville, Tracey, Limdi, Jimmy, Kok, Klaartje B, Fraser, Aileen, Kent, Alexandra, Mulgabal, Khasia, Nelson-Piercy, Catherine, Selinger, Christian

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

    Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab by Lin, Simeng, Kennedy, Nicholas A., Saifuddin, Aamir, Sandoval, Diana Muñoz, Reynolds, Catherine J., Seoane, Rocio Castro, Kottoor, Sherine H., Pieper, Franziska P., Lin, Kai-Min, Butler, David K., Chanchlani, Neil, Nice, Rachel, Chee, Desmond, Bewshea, Claire, Janjua, Malik, McDonald, Timothy J., Sebastian, Shaji, Alexander, James L., Constable, Laura, Lee, James C., Murray, Charles D., Hart, Ailsa L., Irving, Peter M., Jones, Gareth-Rhys, Kok, Klaartje B., Lamb, Christopher A., Lees, Charlie W., Altmann, Daniel M., Boyton, Rosemary J., Goodhand, James R., Powell, Nick, Ahmad, Tariq

    Published in Nature communications
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Nutritional care pathways in cancer patients with malignant bowel obstruction: A retrospective multi-centre study

    Nutritional care pathways in cancer patients with malignant bowel obstruction: A retrospective multi-centre study by Patel, Pinal S, Fragkos, Konstantinos, Keane, Niamh, Wilkinson, David, Johnson, Amy, Chan, Derek, Roberts, Bradley, Neild, Penny, Yalcin, Metin, Allan, Philip, FitzPatrick, Michael E B, Gomez, Michael, Williams, Sarah, Kok, Klaartje, Sharkey, Lisa, Swift, Carla, Mehta, Shameer, Naghibi, Mani, Mountford, Christopher, Forbes, Alastair, Rahman, Farooq, Di Caro, Simona

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: